Radiological Bone Loss on Different Levels of Dental Implants
Alveolar Bone Loss, Peri-Implantitis, Bone Loss in Jaw
About this trial
This is an interventional treatment trial for Alveolar Bone Loss focused on measuring vertical mucosal height, dental implant, marginal bone loss, keratinized gingival width
Eligibility Criteria
Inclusion Criteria:
- >18 years old
- The patient does not have any systemic disease
- Implants are placed in the fully healed alveolar bone
- There is no need for horizontal and vertical augmentation in the area where the implant will be placed.
- Interocclusal distance higher than 7 mm
- Cooperative patients
- At least 9 mm of alveolar bone in the patient's mandible or maxilla in the area where the implant will be placed
Exclusion Criteria:
- Pregnant and lactation
- Mentally retarded patients
- Immediate loading
- Alveolar bone defects
- Smoking more than 10 cigarettes per a day
- Immunsupression or deficiency on bone metabolism
Sites / Locations
- Kütahya Health Sciences University Faculty of Dentistry, Department of Periodontology
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
equicrestally placement with higher vertical mucosa
subcrestally placement with higher vertical mucosa
equicrestally placement with less vertical mucosa
subcrestally placement with less vertical mucosa
Implants with a vertical mucosal height greater than 2 mm (A) and placed equicrestally (I) are in group A-I.
Implants with a vertical mucosal height greater than 2 mm (A) and placed subcrestally (II) are in group A-II.
Implants with a vertical mucosal height of 2 mm or less (B) and placed equicrestally (I) are in group B-I.
Implants with a vertical mucosal height of 2 mm or less (B) and placed subcrestally (II) are in group B-II.